Active Shortage

NAT-ERIBULIN

NATCO PHARMA (CANADA) INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NAT-ERIBULIN in Canada?

Yes. NAT-ERIBULIN 0.5MG has an active shortage reported to Health Canada (last updated July 22, 2026).

Why is NAT-ERIBULIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will NAT-ERIBULIN be available again?

The manufacturer's estimated resolution date is August 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~10 months remaining (estimate)

Affected strength0.5MG

Report last updated2026-07-22

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

HALAVEN

EISAI LIMITED

0.5MG · DIN 02377438

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ERIBULIN MESYLATE INJECTION

MARCAN PHARMACEUTICALS INC

0.5MG · DIN 02564467

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02539136

Strength

0.5MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

ERIBULIN MESYLATE

See all ERIBULIN MESYLATE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-07-22

Active Shortage

Disruption of the manufacture of the drug.

Other Products from NATCO PHARMA (CANADA) INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

250MG · DIN 02494132

1MG · DIN 02417855

5MG · DIN 02492822

2.5MG · DIN 02492814

100MG · DIN 02496895

25MG · DIN 02496887